AstraZeneca Hit With Investor Suit Over COVID-19 Vaccine
An AstraZeneca investor filed a putative class action in New York federal court Friday accusing the biopharmaceutical giant of withholding information about its COVID-19 vaccine candidate, misleading the public about the...To view the full article, register now.
Already a subscriber? Click here to view full article